US 8080554
Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation
granted A61KA61K2039/55561A61K31/00
Quick answer
US patent 8080554 (Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Dec 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary of the Department of Health and Human Services
- Grant date
- Tue Dec 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 34
- CPC classes
- A61K, A61K2039/55561, A61K31/00, A61K31/365, A61K31/519